Peer Review History

Original SubmissionMarch 9, 2023
Decision Letter - Philip A. Cola, Editor

PONE-D-23-06594Clinical leaders crossing boundaries: a study on the role of clinical leadership in crossing boundaries between specialties.PLOS ONE

Dear Dr. Braam,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We are very interested to have reviewed your important study around relational coordination and boundary spanning across clinical leaders.  We believe that improved collaboration and transdisciplinary clinical environments will benefit patients and care givers alike.  However, a main aim of the study around the relational coordination and patient outcomes does not seem to be addressed clearly in the outcomes of the paper.  Furthermore, there does not appear to be direct empirical evidence of meaningful patient outcomes related especially to those with co-morbidities that improve based on the data from the relational coordination scores.  It seems that perhaps the data needs to be analyzed a bit more in depth to answer directly these aims or goals of this study.  It is believed that the data is available in this sample, but not analyzed perhaps in depth enough to answer the main questions directly. Additionally, some participants are leaders and others are not leaders (at least not yet) and therefore this mixed sample could potentially introduce bias into the results that have been provided or that we are now currently asking for more details on.  Please address the potential for bias as all participants are not at leadership positions currently.  Finally, also see the detailed comments from the reviewers of the manuscript.

Please submit your revised manuscript by Jul 28 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Philip A. Cola, Ph.D.

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

“The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The study addresses a very important barrier to successful patient care, especially considering patients with multiple comorbidities, and is an important insight into the importance of relational coordination in the hospital setting. In particular, the authors show an important correlation between relational coordination and several important qualities contributing to successful medical care, including care quality, leadership, and job satisfaction both within and between specialties. However, a more in-depth analysis of the survey data, a modification of the study aims/conclusions, and edits to improve clarity would be very useful to improve the manuscript.

Major Points:

The associations between relational coordination and patient outcomes, as stated as the aim of the study, are not addressed. There is no evidence provided of tangible or other reported patient outcomes (particularly, patients with co-morbidities) in different thematic units is correlated to relational coordination score, and the score of physician assessment of their own quality care introduces a major bias despite “proven validity”. Several participants also had formal leadership positions, which may further bias the study results. To prove this claim, the authors should ask question of care satisfaction to their target population – patients with comorbidities – and correlate with the thematic unit responsible for care, if possible.

It would be helpful to have a more in-depth analysis of the correlation of individual questions and points with outcomes, not just as grouped under “relational coordination.” For example, how do the individual components of communication (frequency, timeliness, etc.) correlate with quality of care? Additionally, a differentiation of how responders that hold formal leadership positions responses differ from those that do not could be informative to support several claims in the manuscript.

A more detailed explanation of how to read Table 1 should be provided in the legend to assist with interpretation.

The analysis of the stronger association with the outcome of job satisfaction and relational coordination seems to be biased considering the strong associations between other measured items (i.e. between clinical leadership (group 1) and relational coordination (group 3)) and that these are different based on relational coordination from same specialty group or different specialty groups. More thought should be placed on how those high Pearson product-moment correlations impact the study.

The authors conclude that clinicians should strive to be clinical leaders, which goes hand in hand with job satisfaction. However, there does not seem to be a metric about clinician desire to be an official leader (e.g., have a leadership role in the future, head a department, etc) and how that correlates with relational coordination scores. This would be an important data point to support that claim.

If possible, a supplementary table of questions that were provided to participants should be provided.

Some conclusions made in the manuscript are not entirely supported by the data. For example, the conclusion that this study shows clinical leaders that demonstrate behaviors such as enabling others to act and sharing an inspiring vision will most likely contribute to the improvement strategies is not proven with the data provided. More thought should be given to claims made throughout the text, and they should be modified based off of what the results of the survey support.

Minor Points:

Several hypotheses are provided in the introduction of the manuscript. The study might benefit from consolidating hypotheses into one over-arching hypotheses for clarity and for conciseness.

The main manuscript text can get repetitive, especially in the background section. It could benefit from revision to make points more concise.

The discussion could be expanded to include future directions and additional areas where this survey could be applicable.

Reviewer #2: Review PONE-D-23-06594

Clinical leaders crossing boundaries: a study on the role of clinical leadership in

crossing boundaries between specialties

Thank you for the opportunity to review this important topic.

This article describes the results of a cross-sectional study evaluating the impact of clinical leadership on physicians’ care quality and job satisfaction as mediated by with and between group relational coordination. This study joins a significantly large body of literature on the role of relational coordination in worker wellbeing and work outcomes in general, and an increasingly important area of interest in health care.

Abstract: implications for practice seems a bit odd as the research does not aim to justify continued specialty practice teams. Please consider an implication more closely tied to the importance of promoting relational coordination among physicians and how this might consistently and systematically promoted.

Background:

Line 72. Please add a brief definition of clinical leadership or strong clinical leadership

Line 85-86. Please provide an example or explanation as to why it is more difficult for physicians from different medical specialties to effectively coordinate care

Line 90-91. This information is repeated in the previous paragraph, please revise

Line118 consider choosing just one term: physician versus doctor.

Line 119. Please add a example following this sentence “Although doctors lead from the day they start clinical practice, crossing medical specialist boundaries might be more demanding”

Line 131-133. Suggest moving “a” to precede the first instance of “relational coordination” in the hypothesis so that is reads: Hypothesis 3: Clinical leadership behaviors are positively related to (a) relational coordination among physicians within their medical specialty group and (b) relational coordination among physicians from different medical specialties.

Methods

Line 252. Change ‘respondents’ to participants’

Line 270-271. Change the sentence to read: Participants first agreed to participate in the study before data collection and their identities are kept confidential.

Discussion:

Line 374. please provide elaboration on Amy Edmondson’s work by describing a teaming application appropriate for physician practice and multimorbid care collaboration

Line 387. insert ‘as’ between “such social” to read “ such as social desirability”

Line 390. Suggest adding “ and care coordination” at the end of the sentence

Practical Implications:

As in the abstract, it seems odd to justify the need for specialty group practice. Perhaps adding that more structure/intervention/purposeful socialization is needed between areas of specialty practice in order to take advantage of expertise toward patients’ benefit

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Rebecca R. Kitzmiller

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Please see the attached file: Response to Reviewers

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Philip A. Cola, Editor

Clinical leaders crossing boundaries: a study on the role of clinical leadership in crossing boundaries between specialties.

PONE-D-23-06594R1

Dear Dr. Braam,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Philip A. Cola, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

I very much appreciated your detailed and thorough response to the reviewers' comments and my comments as well. I find your responses each to be acceptable. I also appreciated the cleanly edited manuscript with tracked changes and comments. With these changes, I recommend accepting the manuscript as revised.

Formally Accepted
Acceptance Letter - Philip A. Cola, Editor

PONE-D-23-06594R1

Clinical leaders crossing boundaries: A study on the role of clinical leadership in crossing boundaries between specialties.

Dear Dr. Braam:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Philip A. Cola

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .